Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Leptin May Help Solve Obesity Problem

By Biotechdaily staff writers
Posted on 19 Feb 2004
Researchers have found that increasing leptin in laboratory animals transforms fat-storing cells into unique fat-burning cells, which has led them to speculate that this could provide "a quick and safe solution” to obesity in humans. More...
Their findings were published in the February 9, 2004, online issue of Proceedings of the [U.S.] National Academy of Sciences.

Researchers from the University of Texas Southwestern Medical Center at Dallas (USA) collaborated with scientists at the University of Geneva Medical School (Switzerland) who conducted morphologic tests to analyze the form and structure of the cells. They found that instead of containing fat, the cells were crowded with mitochondria. Some of the lab animals received an intravenous injection of the leptin gene, which was expressed in and produced by the liver. Leptin levels rose 50 times greater than normal in rats after two to four days before tapering off. The remaining animals followed a restricted diet, and were constantly searching for food. The rats receiving leptin injections experienced a rapid and profound weight loss.

Leptin produced by fat cells does not ordinarily interfere with the accumulation of surplus fat, but leptin secreted by the liver does and actually causes the surplus to burn up. "We would like to break down the normal defense system against leptin produced in the fat cell. If we could disable or bypass this system and transform fat (storing) cells into fat-burning cells, then we may be a step closer to solving the obesity problem,” said senior author Roger Unger, M.D., director of the Touchstone Center for Diabetes Research at UT Southwestern.




Related Links:
UT Southwestern
U. of Geneva

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Multi-Chamber Washer-Disinfector
WD 390
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.